In this presentation, Anand A. Patel, MD, reviewed the contemporary standard-of-care treatment roadmap for AML in 2025, covering key phases like induction chemotherapy (eg, the “7+3” regimen), consolidation…
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York, discusses the treatment strategies for patients who develop secondary acute myeloid leukemia (AML) following hypomethylating agent…
NEW YORK (Reuters Health) – A preoperative MRI showing whether or not a rectal tumor encroaches on the circumferential resection margin (CRM) is a better predictor of recurrence…
Martin Lee, author of Smoke Signals, and director of Project CBD, explains why doctors may find themselves in a difficult position when patients come to them with questions about medical…
Martin Lee, author of Smoke Signals, and director of Project CBD, discusses the results of a University of Calgary study that found New Yorkers suffering from PTSD after the…
Nancy Simonian, MD, CEO, Syros Pharmaceuticals explains that by modulating components of super-enhancers, important genes that drive disease states may be able to be turned down. She references a recent…
Martin Lee, author of Smoke Signals, and director of Project CBD, discusses the enlightening research coming out of the California Pacific Medical Center about the antitumor and anticancer effects of cannabinoids.…
NEW YORK (Reuters Health) – While pancreatic cancer mortality is still higher among blacks than whites in the US, rates are decreasing among blacks and increasing among whites,…
NEW YORK (Reuters Health) – In the neoadjuvant treatment of HER2-positive breast cancer, administering trastuzumab concurrently with anthracyclines offers no advantage over sequential administration, according to the results…
NEW YORK (Reuters Health) – Compared to single-agent platinum chemotherapy, platinum-combination chemotherapy improves survival in patients with recurrence of ovarian cancer, a meta-analysis has shown. The researchers say…
NEW YORK (Reuters Health) – Results of a randomized trial conducted in Italy indicate that conventional external radiotherapy (RT) after breast conserving surgery for early breast cancer is…
NEW YORK (Reuters Health) – In hospitalized cancer patients, the common problem of hyponatremia can be corrected by administration of the orally active V2 receptor antagonist, tolvaptan. The…
